secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition II Corp. (DMII)
CIK:        0002040475
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001213900-25-093224
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC Drugs Made In America Acquisition II Corp. closes $500M IPO; $500M in trust
--------------------------------------------------------------------------------

- Priced and closed IPO of 50M units at $10/unit for gross proceeds of $500M.
- Concurrent private placement of 1.2M units ($12M) to sponsor and Cantor Fitzgerald.
- Net proceeds of $500M deposited into trust account for public shareholders.
- Units trade on Nasdaq under DMIIU; ordinary shares and rights to trade separately later.
- Appointed Catherine Do, G. Sridhar Prasad, Myron W. Shulgan to board and committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/0001213900-25-093224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea0258969-8k_drugs2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-093224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer